Abstract:
The invention relates to a method for producing a headlamp lens (2) for a vehicle headlamp, in particular for a motor-vehicle headlamp (1), wherein the headlamp lens (2) comprises a transparent body (3) with an optically effective surface (5), which is in particular substantially planar and can be turned towards a light source (10), and an optically effective surface (4), which is in particular convex and can be turned away from the light source (10), wherein the gradient of a light-dark boundary (25) projected by the headlamp lens (2) or a further headlamp lens is measured, and wherein a light diffusing structure (35) is produced in the transparent body (3) in accordance with the measured gradient.
Abstract:
A vehicle headlamp includes a first light source, at least one second light source and an integrally designed, transparent shaped part. The shaped part includes a first optical structure for orienting light radiated by the first light source and at least one second optical structure for orienting light radiated by the second light source. The first optical structure and the second optical structure each have a continuously curved surface or a continuous, curved surface with an extent of at least in each case half a centimeter, in particular one centimeter, in two orthogonal directions.
Abstract:
The invention relates to a vehicle headlamp (1), in particular motor vehicle headlamp (1), with a first light source (10), with at least one second light source (24) and with an integrally designed, transparent shaped part (2), wherein the shaped part (2) comprises a first optical structure (3) for orienting light radiated by the first light source (10) and at least one second optical structure (4) for orienting light radiated by the second light source (24), and wherein the first optical structure (3) and the second optical structure (4) each have a continuously curved surface or a continuous, curved surface with an extent of at least in each case half a centimetre, in particular one centimetre, in two orthogonal directions.
Abstract:
A high gold content dental alloy comprises, on a weight basis, 91 to 99.4% of gold, 0.5 to 3% of at least one metal selected from titanium and tantalum, up to 5% of silver, 0.05 to 1% of iridium and/or tungsten, and up to 1% at least one element selected from the group comprising rhodium, ruthenium, platinum, osmium, iron, molybdenum, niobium and rhenium.
Abstract:
A method for animating a map resource is provided, the method includes receiving a plurality of Uniform Resource Locators (URLs) from a third party website, the plurality of URLs comprising one or more attributes; receiving a user selection to create an animation sequence of one or more of the attributes; querying a current value of the one or more attributes from an external resource and returning the queried value; receiving, from the user, a first keyframe and a second keyframe for the animation sequence; interpolating one or more additional keyframes with assigned values; and creating the animation sequence based on the first keyframe, the second keyframe, and the one or more additional keyframes.
Abstract:
A process for manufacturing a ceramic implant with a surface which forms a permanent bonding to bone cell tissues, the surface providing improved osseointegration, the process comprising the step of:—a pretreatment of the ceramic material with the surface wherein said surface of the ceramic material is exposed to a conditioning plasma, which is produced by means of direct current (DC) or alternating current (AC), such as high or radio frequency (HF, RF), or microwaves (MW) at a low pressure, followed by a second step;—a treatment with a reactive plasma in which an organic compound is added to the plasma for the at least partial application of an organic phase to said surface wherein the organic compound is selected from the group consisting of aliphatic amines, cyclic amines, unsaturated and aromatic amines as well as combinations thereof.
Abstract:
An antibody binding to IL33R characterized in that the heavy chain variable domain comprises a CDR3 region of SEQ ID NO:1, a CDR2 region of SEQ ID NO:2 and a CDR1 region of SEQ ID NO:3 and in that the light chain variable domain comprises a CDR3 region of SEQ ID NO:4, a CDR2 region of SEQ ID NO:5 and a CDR1 region of SEQ ID NO:6 or a chimeric, humanized or T cell epitope depleted antibody variant thereof has advantageous properties for the treatment of inflammatory diseases.
Abstract translation:结合IL33R的抗体,其特征在于重链可变结构域包含SEQ ID NO:1的CDR3区,SEQ ID NO:2的CDR2区和SEQ ID NO:3的CDR1区,并且其中轻链可变区 结构域包含SEQ ID NO:4的CDR3区,SEQ ID NO:5的CDR2区和SEQ ID NO:6的CDR1区或嵌合,人源化或T细胞表位缺失的抗体变体具有治疗的有利性质 的炎性疾病。
Abstract:
A circuit arrangement for automatic gain control of NRZ data signals. In this arrangement there is detected with the aid of two comparators whether a logic level in the NRZ data signal produced by a controllable amplifier is exceeded or fallen short of. The signals produced by the comparators are time-averaged with the aid of RC combinations and subjected to a logic AND combination. The signal available at the output of the AND combination is integrated in an integrator stage and transported as a control signal to a set input of the controllable amplifier.